Evidence map›Paper›PMID 30852535›Full record

ArticleBMJ open2019

Serological surveillance of influenza in an English sentinel network: pilot study protocol.

Simon de Lusignan, Ray Borrow, Manasa Tripathy, Ezra Linley, Maria Zambon, Katja Hoschler, Filipa Ferreira, Nick Andrews, Ivelina Yonova, Mariya Hriskova and 2 more

Abstract read
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Rapidly adapting primary care sentinel surveillance across seven countries in Europe for COVID-19 in the first half of 2020: strengths, challenges, and lessons learned.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Simon de LusignanDepartment of Clinical and Experimental Medicine, University of Surrey, Guildford, UK.
Ray BorrowVaccine Evaluation Unit, Manchester Royal Infirmary, Public Health England, Manchester, UK.
Manasa TripathyDepartment of Clinical and Experimental Medicine, University of Surrey, Guildford, UK.
Ezra LinleyVaccine Evaluation Unit, Manchester Royal Infirmary, Public Health England, Manchester, UK.
Maria ZambonPublic Health England, London, UK.
Katja HoschlerPublic Health England, London, UK.
Filipa FerreiraDepartment of Clinical and Experimental Medicine, University of Surrey, Guildford, UK.
Nick AndrewsModelling and Economics Department, Public Health England, London, UK.
Ivelina YonovaDepartment of Clinical and Experimental Medicine, University of Surrey, Guildford, UK.
Mariya HriskovaDepartment of Clinical and Experimental Medicine, University of Surrey, Guildford, UK.
Imran RafiClinical Innovation and Research Centre (CIRC), Royal College of General Practitioners, London, UK.
Richard PebodyCentre for Infectious Disease Surveillance and Control, Public Health England, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRapidly undertaken age-stratified serology studies can produce valuable data about a new emerging infection including background population immunity and seroincidence during an influenza pandemic. Traditionally seroepidemiology studies have used surplus laboratory sera with little or no clinical information or have been expensive detailed population based studies. We propose collecting population based sera from the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC), a sentinel network with extensive clinical data.

aimTo pilot a mechanism to undertake population based surveys that collect serological specimens and associated patient data to measure seropositivity and seroincidence due to seasonal influenza, and create a population based serology bank. METHODS AND ANALYSIS:

methodsWe will send the samples to the Public Health England (PHE) Seroepidemiology Unit for processing and storage. These samples will be tested for influenza antibodies, using haemagglutination inhibition assays. Serology results will be pseudonymised, sent to the RCGP RSC and combined using existing processes at the RCGP RSC secure hub. The influenza seroprevalence results from the RCGP cohort will be compared against those from the annual PHE influenza residual serosurvey. ETHICS AND DISSEMINATION: Ethical approval was granted by the Proportionate Review Sub- Committee of the London - Camden & Kings Cross on 6 February 2018. This study received approval from Health Research Authority on 7 February 2018. On completion the results will be made available via peer-reviewed journals.

Indexed as

Sentinel SurveillanceAdultAgedEnglandFemaleHumansInfluenza, HumanInfluenza VaccinesMaleMiddle AgedPilot ProjectsSeroepidemiologic StudiesYoung AdultInfluenza Vaccinesdata collectioninfluenza, humanmedical records systems, computerizedpandemicspopulation surveillanceprimary health carerecords as topicseroepidemiologic studiesserology

Identifiers

PMID30852535
PMCPMC6429844

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.